Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Clinical trial NCT03756883 · COMPLETED
Trial details
- NCT number
- NCT03756883
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2019-10-26
- Enrollment
- 999
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.